80 participants
A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-11-28
- Start Date:
- 2013-07-16
- Completion:
- 2017-06-09
Conditions
- Breast Cancer, Non-small Lung Cancer
Interventions
- DRUG
No Results Yet